A detailed history of Diversified Trust CO transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 15,240 shares of PTCT stock, worth $740,816. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,240
Previous 15,317 0.5%
Holding current value
$740,816
Previous $468,000 20.73%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$30.39 - $37.66 $2,340 - $2,899
-77 Reduced 0.5%
15,240 $565,000
Q2 2024

Jul 16, 2024

BUY
$24.69 - $40.12 $20,196 - $32,818
818 Added 5.64%
15,317 $468,000
Q1 2024

Apr 18, 2024

BUY
$24.15 - $31.95 $7,124 - $9,425
295 Added 2.08%
14,499 $421,000
Q4 2023

Jan 08, 2024

BUY
$18.07 - $29.37 $16,190 - $26,315
896 Added 6.73%
14,204 $391,000
Q3 2023

Nov 17, 2023

BUY
$22.41 - $41.99 $7,126 - $13,352
318 Added 2.45%
13,308 $298,000
Q2 2023

Jul 18, 2023

BUY
$40.4 - $59.1 $28,078 - $41,074
695 Added 5.65%
12,990 $528,000
Q1 2023

Apr 07, 2023

BUY
$38.16 - $48.86 $145,236 - $185,961
3,806 Added 44.83%
12,295 $595,000
Q4 2022

Jan 17, 2023

SELL
$33.53 - $54.79 $301 - $493
-9 Reduced 0.11%
8,489 $324,000
Q3 2022

Oct 14, 2022

BUY
$41.85 - $53.85 $17,660 - $22,724
422 Added 5.23%
8,498 $427,000
Q2 2022

Jul 12, 2022

SELL
$25.6 - $45.23 $1,254 - $2,216
-49 Reduced 0.6%
8,076 $324,000
Q1 2022

Apr 07, 2022

SELL
$33.33 - $44.6 $8,399 - $11,239
-252 Reduced 3.01%
8,125 $303,000
Q4 2021

Jan 13, 2022

BUY
$35.36 - $41.86 $296,210 - $350,661
8,377 New
8,377 $334,000
Q4 2020

Jan 08, 2021

SELL
$47.96 - $67.64 $290,829 - $410,168
-6,064 Closed
0 $0
Q3 2020

Oct 15, 2020

SELL
$45.41 - $57.07 $11,034 - $13,868
-243 Reduced 3.85%
6,064 $283,000
Q2 2020

Jul 07, 2020

BUY
$42.56 - $54.98 $268,425 - $346,758
6,307 New
6,307 $320,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.48B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.